Stay updated on GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page
- Check6 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a new site revision.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.6.3 has been added, replacing Revision: v3.6.2. This indicates a minor update to the study record page.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2. This reflects an internal page update that does not change the displayed study information.SummaryDifference0.2%

- Check41 days agoChange DetectedThere are no changes detected on the page. The content remains as previously published, including study details, eligibility criteria, and locations.SummaryDifference0.1%

- Check49 days agoChange DetectedRecruitment status updated to No longer looking for participants, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment label was reformatted and a revision note shows v3.6.0.SummaryDifference0.5%

- Check56 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, reflecting a small maintenance update to the page's documentation/versioning.SummaryDifference0.1%

Stay in the know with updates to GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.